JP Morgan Maintains Neutral on Surgery Partners, Lowers Price Target to $40

JP Morgan analyst Lisa Gill maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and lowers the price target from $45 to $40.

JP Morgan analyst Lisa Gill maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and lowers the price target from $45 to $40.

Total
0
Shares
Related Posts